Yahoo News: Cancer

Study: Cancer risk eases in Southern California

Thu, 10/02/2014 - 20:29
LOS ANGELES (AP) — By at least one measure, Southern California's air is getting healthier.

Ariad Pharma's lung cancer drug gets breakthrough therapy status

Thu, 10/02/2014 - 14:12
(Reuters) - Ariad Pharmaceuticals Inc said its experimental lung cancer drug was granted "breakthrough therapy" status by the U.S. Food and Drug Administration, sending the company's shares up as much as 13 percent. The designation hastens the development and review periods of a drug that shows evidence of providing improvement over existing treatment for patients with serious diseases. The drug ...

Now you can help Ms. Pac-Man fight breast cancer

Wed, 10/01/2014 - 20:00
Ms. Pac-Man is joining the fight against breast cancer. For the month of October, Bandai Namco mobile games will offer an extra pink maze to its Pac-Man mobile games, costing $0.99. All proceeds go to the National Breast Cancer Foundation.

Pac-Man Franchise Launches Campaign to Fight Breast Cancer

Wed, 10/01/2014 - 18:13
All proceeds from the sale of $1 iOS and Android game DLC will go to the National Breast Cancer Foundation.

New cancer therapy comes of age, cost a 'toxic' side effect

Tue, 09/30/2014 - 14:39
By Ben Hirschler MADRID (Reuters) - A raft of new cancer drugs promise better, longer-lasting treatments with fewer adverse side effects -- but their high cost is a growing concern. Drugs that help the body's own immune cells fight tumors are expected to be used in multi-drug cocktails, pushing the price of therapies costing more than $100,000 a year even higher. At the same time, other ...

Despite insurance, 1 in 3 cancer survivors incur $10,000+ debt

Tue, 09/30/2014 - 11:35
Even those with solid insurance plans find that cancer treatments leave them deep in debt.

Study examines cancer risk from 1st atom-bomb test

Mon, 09/29/2014 - 21:08
ALBUQUERQUE, N.M. (AP) — Researchers from the National Cancer Institute want to know how many past and present cancer cases in New Mexico may be related to the U.S. government's test of the world's first atomic bomb over a remote stretch of desert nearly 70 years ago.

Cancer doctor given 10 years for poisoning lover

Mon, 09/29/2014 - 20:58
A jury has sentenced a Texas cancer researcher to 10 years in prison after she was convicted of poisoning her colleague, who was also her lover, by lacing his coffee with a chemical found in antifreeze.

5-year-old cancer patient's 'commercial' on bravery will inspire you, reduce you to tears

Mon, 09/29/2014 - 20:45
"If you have cancer, don't worry," Hannah Higgins says in the two-minute video. "'Cause I am brave, and you can be brave also."

Can Aspirin Cut Your Risk of Cancer?

Mon, 09/29/2014 - 17:46
It might be hard to believe that the little white pill you've probably taken primarily for headache relief could be powerful enough to stave off a disease as dangerous as cancer, but two new studies confirm aspirin's anti-inflammatory effect -- one factor that could lead to reduced cancer risk.

BRCA Gene Mutations Linked to Salivary Gland Cancer

Mon, 09/29/2014 - 14:41
The genetic mutations that put people at high risk for breast cancer may also be linked with an increased risk of salivary gland cancer, a new study suggests. Researchers analyzed information from 187 people with breast cancer who had mutations in the BRAC1 and BRAC2 genes — which are linked with a high risk of breast and ovarian cancer. The researchers also examined several generations of ...

Seattle Genetics, Takeda's cancer drug meets main goal in trial

Mon, 09/29/2014 - 11:46
(Reuters) - Seattle Genetics Inc and Takeda Pharmaceutical Co Ltd said their approved cancer drug was successfully used as a consolidation therapy in a late-stage trial for patients with a type of lymphatic cancer. Consolidation therapy is given to cancer patients who have undergone initial therapy and kills any cancer cells that may be left in the body. ...

Merck immunotherapy drug shows promise in bladder cancer

Mon, 09/29/2014 - 09:19
MADRID (Reuters) - Merck & Co's new immune system drug Keytruda has produced encouraging results in early tests against bladder cancer, according to a company-sponsored study, prompting the firm to prepare a clinical trial later this year. Keytruda is the first in a new wave of immune-boosting medicines to be approved for treating melanomas in the United States, but it also has potential in a ...

Roche breast cancer drug 'helps patients live longer'

Sun, 09/28/2014 - 22:48
Geneva (AFP) - A drug developed by Swiss giant Roche to treat an aggressive form of breast cancer has been shown to extend patients' lives by almost 16 months, researchers said Sunday.

Gain from adding Roche's Avastin to immune drug unclear

Sun, 09/28/2014 - 15:57
By Ben Hirschler MADRID (Reuters) - It is too early to say whether combining Roche's best-selling Avastin cancer drug with the company's experimental immune-boosting medicine MPDL3280A gives a better outcome in fighting tumors. That is the verdict of experts following a presentation of a small clinical study assessing the combination in patients with a variety of solid tumors. ...

Failed cancer vaccines might live again with new immune drugs

Sun, 09/28/2014 - 09:31
By Ben Hirschler MADRID (Reuters) - Using vaccines to fight cancer is a field littered with failures but experts believe it is possible the approach could get a new lease of life if such shots are combined with a new class of drugs called checkpoint inhibitors. Unlike traditional preventative vaccines, therapeutic cancer vaccines are designed for people with established disease and are supposed ...

Merck drug extends immune system fight to stomach cancer

Sun, 09/28/2014 - 07:51
By Ben Hirschler MADRID (Reuters) - Merck & Co's drug Keytruda, the first in a new wave of immune-boosting medicines to be approved for treating melanomas in the United States, also has potential in stomach cancer, new research shows. Early clinical trial results reported on Sunday mean that gastric, or stomach cancer can be added to a growing list of tumor types where so-called immunotherapy ...

Roche breast cancer drug shows 'unprecedented' survival benefit

Sun, 09/28/2014 - 07:15
By Ben Hirschler MADRID (Reuters) - A new breast cancer drug from Roche has shown "unprecedented" survival benefits in a clinical trial, boosting prospects for its widespread use in women with an aggressive form of the disease. Patients with a type of breast cancer known as HER-2 positive, which makes up about a quarter of all breast cancers, who were given Perjeta on top of older medicine ...

No benefit from continued use of AstraZeneca's Iressa drug

Sun, 09/28/2014 - 07:13
By Ben Hirschler MADRID (Reuters) - Continuing to give AstraZeneca's drug Iressa plus chemotherapy to lung cancer patents whose disease has worsened after previously taking the medicine on its own does not provide any benefit. Some doctors had hoped that extending the use of Iressa in combination with chemotherapy would help to keep cancers at bay, even when tumor cells had started to develop ...